WallStreetZenWallStreetZen

NASDAQ: CORT
Corcept Therapeutics Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for CORT

Based on 3 analysts offering 12 month price targets for Corcept Therapeutics Inc.
Min Forecast
$30.00+31.23%
Avg Forecast
$31.00+35.61%
Max Forecast
$33.00+44.36%

Should I buy or sell CORT stock?

Based on 3 analysts offering ratings for Corcept Therapeutics Inc.
Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CORT stock forecasts and price targets.

CORT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 4%
4
BuyMaintains$33.00+44.36%2022-08-04
Truist Securities
Bottom 13%
13
HoldDowngrades$30.00+31.23%2022-08-01
Canaccord Genuity
Bottom 3%
3
Strong BuyInitiates Coverage On$30.00+31.23%2022-02-02

1 of 1

Forecast return on equity

Is CORT forecast to generate an efficient return?
Company
41.39%
Industry
15.35%
Market
62.84%
CORT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CORT forecast to generate an efficient return on assets?
Company
36.74%
Industry
13.55%
CORT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CORT earnings per share forecast

What is CORT's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$0.88-18.52%
Avg 2 year Forecast
$1.04-3.7%
Avg 3 year Forecast
$1.40+29.63%
CORT's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

CORT revenue forecast

What is CORT's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$415.7M+4.54%
Avg 2 year Forecast
$459.2M+15.47%
Avg 3 year Forecast
$507.7M+27.69%
CORT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CORT earnings growth forecast

How is CORT forecast to perform vs Biotechnology companies and vs the US market?
Company
7.77%
Industry
7.94%
Market
17.02%
CORT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CORT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CORT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CORT revenue growth forecast

How is CORT forecast to perform vs Biotechnology companies and vs the US market?
Company
8.49%
Industry
24.83%
Market
6.69%
CORT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CORT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CORT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CORT$22.86$31.00+35.61%Buy
AMLX$37.19$47.50+27.72%Buy
SAGE$41.61$52.17+25.37%Buy
PROK$10.49$15.67+49.35%Strong Buy
ACAD$14.90$22.25+49.33%Hold

Corcept Therapeutics Stock Forecast FAQ

Is Corcept Therapeutics Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CORT) stock is to Buy CORT stock.

Out of 3 analysts, 1 (33.33%) are recommending CORT as a Strong Buy, 1 (33.33%) are recommending CORT as a Buy, 1 (33.33%) are recommending CORT as a Hold, 0 (0%) are recommending CORT as a Sell, and 0 (0%) are recommending CORT as a Strong Sell.

If you're new to stock investing, here's how to buy Corcept Therapeutics stock.

What is CORT's earnings growth forecast for 2022-2024?

(NASDAQ: CORT) Corcept Therapeutics's forecast annual earnings growth rate of 7.77% is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.94%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Corcept Therapeutics's earnings in 2022 is $116,798,000.On average, 4 Wall Street analysts forecast CORT's earnings for 2022 to be $94,731,872, with the lowest CORT earnings forecast at $93,655,373, and the highest CORT earnings forecast at $97,961,367. On average, 5 Wall Street analysts forecast CORT's earnings for 2023 to be $111,955,848, with the lowest CORT earnings forecast at $89,349,379, and the highest CORT earnings forecast at $139,944,810.

In 2024, CORT is forecast to generate $150,709,796 in earnings, with the lowest earnings forecast at $133,485,819 and the highest earnings forecast at $161,474,781.

What is CORT's revenue growth forecast for 2022-2024?

(NASDAQ: CORT) Corcept Therapeutics's forecast annual revenue growth rate of 8.49% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 24.83%, and while it is forecast to beat the US market's average forecast revenue growth rate of 6.69%.

Corcept Therapeutics's revenue in 2022 is $397,624,000.On average, 3 Wall Street analysts forecast CORT's revenue for 2022 to be $44,746,384,213, with the lowest CORT revenue forecast at $44,362,504,833, and the highest CORT revenue forecast at $44,976,109,001. On average, 3 Wall Street analysts forecast CORT's revenue for 2023 to be $49,428,076,363, with the lowest CORT revenue forecast at $47,761,010,724, and the highest CORT revenue forecast at $50,380,131,672.

In 2024, CORT is forecast to generate $54,654,907,374 in revenue, with the lowest revenue forecast at $52,051,933,905 and the highest revenue forecast at $56,516,173,350.

What is CORT's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: CORT) forecast ROA is 36.74%, which is higher than the forecast US Biotechnology industry average of 13.55%.

What is CORT's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CORT price target, the average CORT price target is $31.00, with the highest CORT stock price forecast at $33.00 and the lowest CORT stock price forecast at $30.00.

On average, Wall Street analysts predict that Corcept Therapeutics's share price could reach $31.00 by Aug 4, 2023. The average Corcept Therapeutics stock price prediction forecasts a potential upside of 35.61% from the current CORT share price of $22.86.

What is CORT's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: CORT) Corcept Therapeutics's current Earnings Per Share (EPS) is $1.08. On average, analysts forecast that CORT's EPS will be $0.88 for 2022, with the lowest EPS forecast at $0.87, and the highest EPS forecast at $0.91. On average, analysts forecast that CORT's EPS will be $1.04 for 2023, with the lowest EPS forecast at $0.83, and the highest EPS forecast at $1.30. In 2024, CORT's EPS is forecast to hit $1.40 (min: $1.24, max: $1.50).

What is CORT's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: CORT) forecast ROE is 41.39%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.